Published in PLoS One on May 19, 2016
Selective in vitro growth of T lymphocytes from normal human bone marrows. Science (1976) 15.73
T cell growth factor receptors. Quantitation, specificity, and biological relevance. J Exp Med (1981) 10.66
A monoclonal antibody that appears to recognize the receptor for human T-cell growth factor; partial characterization of the receptor. Nature (1982) 9.42
Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. N Engl J Med (1985) 8.21
Low and high affinity cellular receptors for interleukin 2. Implications for the level of Tac antigen. J Exp Med (1984) 6.45
Cytokine control of memory T-cell development and survival. Nat Rev Immunol (2003) 5.99
Tolerance, not immunity, crucially depends on IL-2. Nat Rev Immunol (2004) 5.24
Imaging the single cell dynamics of CD4+ T cell activation by dendritic cells in lymph nodes. J Exp Med (2004) 5.08
Novel interleukin-2 receptor subunit detected by cross-linking under high-affinity conditions. Science (1986) 4.30
Structural and practical identifiability analysis of partially observed dynamical models by exploiting the profile likelihood. Bioinformatics (2009) 4.27
IL-2 administration increases CD4+ CD25(hi) Foxp3+ regulatory T cells in cancer patients. Blood (2005) 4.06
The role of interleukin-2 during homeostasis and activation of the immune system. Nat Rev Immunol (2012) 3.97
The interleukin 2 receptor. Functional consequences of its bimolecular structure. J Exp Med (1987) 3.66
Interleukin 2 binding molecule distinct from the Tac protein: analysis of its role in formation of high-affinity receptors. Proc Natl Acad Sci U S A (1987) 2.65
Structure of the quaternary complex of interleukin-2 with its alpha, beta, and gammac receptors. Science (2005) 2.64
Single-cell quantification of IL-2 response by effector and regulatory T cells reveals critical plasticity in immune response. Mol Syst Biol (2010) 2.21
Exploiting a natural conformational switch to engineer an interleukin-2 'superkine'. Nature (2012) 2.08
Heterodimerization of the IL-2 receptor beta- and gamma-chain cytoplasmic domains is required for signalling. Nature (1994) 1.93
Crystal structure of the IL-2 signaling complex: paradigm for a heterotrimeric cytokine receptor. Proc Natl Acad Sci U S A (2006) 1.41
Transcript synthesis and surface expression of the interleukin-2 receptor (alpha-, beta-, and gamma-chain) by normal and malignant myeloid cells. Blood (1996) 1.40
The common gamma-chain for multiple cytokine receptors. Adv Immunol (1995) 1.38
An associated molecule, p64, with IL-2 receptor beta chain. Its possible involvement in the formation of the functional intermediate-affinity IL-2 receptor complex. J Immunol (1992) 1.33
Interleukin 2 receptor gamma chain expression on resting and activated lymphoid cells. J Exp Med (1994) 1.25
IL-2 and IL-15 receptor alpha-subunits are coexpressed in a supramolecular receptor cluster in lipid rafts of T cells. Proc Natl Acad Sci U S A (2004) 1.25
Preassembly of interleukin 2 (IL-2) receptor subunits on resting Kit 225 K6 T cells and their modulation by IL-2, IL-7, and IL-15: a fluorescence resonance energy transfer study. Proc Natl Acad Sci U S A (1997) 1.17
Role for lipid rafts in regulating interleukin-2 receptor signaling. Blood (2001) 1.12
An associated molecule, p64, with high-affinity interleukin 2 receptor. Int Immunol (1990) 1.10
Kinetic analysis of ligand binding to interleukin-2 receptor complexes created on an optical biosensor surface. Protein Sci (1996) 1.08
IL-2 induces conformational changes in its preassembled receptor core, which then migrates in lipid raft and binds to the cytoskeleton meshwork. J Mol Biol (2010) 1.01
Compensatory energetic mechanisms mediating the assembly of signaling complexes between interleukin-2 and its alpha, beta, and gamma(c) receptors. J Mol Biol (2004) 1.01
High-affinity CD25-binding IL-2 mutants potently stimulate persistent T cell growth. Biochemistry (2005) 1.01
A T-cell-selective interleukin 2 mutein exhibits potent antitumor activity and is well tolerated in vivo. Nat Biotechnol (2000) 0.99
Molecular basis for two different affinity states of the interleukin 2 receptor: affinity conversion model. Proc Natl Acad Sci U S A (1986) 0.98
Cell-to-cell variability analysis dissects the plasticity of signaling of common γ chain cytokines in T cells. Sci Signal (2013) 0.97
Interactions between receptors for interleukin 2 and interleukin 4 on lines of helper T cells (HT-2) and B lymphoma cells (BCL1). J Exp Med (1989) 0.95
GPI-microdomains (membrane rafts) and signaling of the multi-chain interleukin-2 receptor in human lymphoma/leukemia T cell lines. Eur J Biochem (2002) 0.93
Endocytosis of the beta chain of interleukin-2 receptor requires neither interleukin-2 nor the gamma chain. Eur J Immunol (1994) 0.90
Human IL-Rbeta chains form IL-2 binding homodimers. Eur Cytokine Netw (2008) 0.89
Differential localization of IL-2- and -15 receptor chains in membrane rafts of human T cells. J Leukoc Biol (2002) 0.88
Engineered interleukin-2 antagonists for the inhibition of regulatory T cells. J Immunother (2009) 0.87
Human IL-2 mutein with higher antitumor efficacy than wild type IL-2. J Immunol (2013) 0.87
Unexpected effects of the IL-2 receptor alpha subunit on high affinity IL-2 receptor assembly and function detected with a mutant IL-2 analog. J Immunol (1993) 0.86
Increased endosomal sorting of ligand to recycling enhances potency of an interleukin-2 analog. J Biol Chem (2000) 0.86
Evidence for p55-p75 heterodimers in the absence of IL-2 from Scatchard plot analysis. Int Immunol (1992) 0.83